KAY CHRISTINA 4
4 · INTEGRATED BIOPHARMA INC · Filed Dec 10, 2025
Insider Transaction Report
Form 4
KAY CHRISTINA
DirectorExecutive Vice President
Transactions
- Award
Stock Option (Right to Buy)
2025-12-09+140,000→ 140,000 totalExercise: $0.35Exp: 2035-12-09→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026.